Journal article · 2016 · Open access

Repurposing the CRISPR-Cas9 system for targeted DNA methylation

Aleksandar Vojta, Paula Dobrinić, Vanja Tadić, Luka Bočkor, Petra Korać, Boris Dominik Jülg, Marija Klasić, Vlatka Zoldoš

Nucleic Acids Research, 44(12), 5615–5628 · Published 11 March 2016 · DOI 10.1093/nar/gkw159

Open PDFView at the publisherCite this paper

In brief

“Repurposing the CRISPR-Cas9 system for targeted DNA methylation” is a 2016 journal article by Aleksandar Vojta and 7 co-authors, published in Nucleic Acids Research. OpenAlex counts 857 citations as of 22 November 2026, which puts it in the top 1% of works published in 2016 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Nucleic Acids Research.

Citations
857
Most cited in
2018 (111)
Field-weighted impact
34.29
References
44
Authors
8

Abstract

Epigenetic studies relied so far on correlations between epigenetic marks and gene expression pattern. Technologies developed for epigenome editing now enable direct study of functional relevance of precise epigenetic modifications and gene regulation. The reversible nature of epigenetic modifications, including DNA methylation, has been already exploited in cancer therapy for remodeling the aberrant epigenetic landscape. However, this was achieved non-selectively using epigenetic inhibitors. Epigenetic editing at specific loci represents a novel approach that might selectively and heritably alter gene expression. Here, we developed a CRISPR-Cas9-based tool for specific DNA methylation consisting of deactivated Cas9 (dCas9) nuclease and catalytic domain of the DNA methyltransferase DNMT3A targeted by co-expression of a guide RNA to any 20 bp DNA sequence followed by the NGG trinucleotide. We demonstrated targeted CpG methylation in a ∼35 bp wide region by the fusion protein. We also showed that multiple guide RNAs could target the dCas9-DNMT3A construct to multiple adjacent sites, which enabled methylation of a larger part of the promoter. DNA methylation activity was specific for the targeted region and heritable across mitotic divisions. Finally, we demonstrated that directed DNA methylation of a wider promoter region of the target loci IL6ST and BACH2 decreased their expression.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Vojta, A., Dobrinić, P., Tadić, V., Bočkor, L., Korać, P., Jülg, B. D., Klasić, M., & Zoldoš, V. (2016). Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Research, 44(12), 5615–5628. https://doi.org/10.1093/nar/gkw159

MLA 9

Vojta, Aleksandar, et al. “Repurposing the CRISPR-Cas9 system for targeted DNA methylation.” Nucleic Acids Research, vol. 44, no. 12, 2016, pp. 5615–5628. https://doi.org/10.1093/nar/gkw159.

Chicago

Vojta, Aleksandar, Paula Dobrinić, Vanja Tadić, Luka Bočkor, Petra Korać, Boris Dominik Jülg, Marija Klasić, and Vlatka Zoldoš. 2016. “Repurposing the CRISPR-Cas9 system for targeted DNA methylation.” Nucleic Acids Research 44 (12): 5615–5628. https://doi.org/10.1093/nar/gkw159.

Harvard

Vojta, A. et al. (2016) ‘Repurposing the CRISPR-Cas9 system for targeted DNA methylation’, Nucleic Acids Research, 44(12), pp. 5615–5628. doi:10.1093/nar/gkw159.

IEEE

A. Vojta et al., “Repurposing the CRISPR-Cas9 system for targeted DNA methylation,” Nucleic Acids Research, vol. 44, no. 12, pp. 5615–5628, 2016, doi: 10.1093/nar/gkw159.

BibTeX

@article{vojta2016repurposing,
  title     = {{Repurposing the CRISPR-Cas9 system for targeted DNA methylation}},
  author    = {Vojta, Aleksandar and Dobrinić, Paula and Tadić, Vanja and Bočkor, Luka and Korać, Petra and Jülg, Boris Dominik and Klasić, Marija and Zoldoš, Vlatka},
  journal   = {Nucleic Acids Research},
  year      = {2016},
  volume    = {44},
  number    = {12},
  pages     = {5615--5628},
  doi       = {10.1093/nar/gkw159},
  url       = {https://doi.org/10.1093/nar/gkw159}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
2017102102
2018111111
20199797
20208484
20218383
20227777
20237373
20245757
20256666
20265959

Its field-weighted citation impact is 34.29: it has been cited 34.29 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering

  • CRISPR/Cas9
  • DNA methylation
  • epigenome editing
  • dCas9
  • DNMT3A
  • targeted DNA methylation
  • CpG methylation
  • guide RNA

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Vojta, A., Dobrinić, P., Tadić, V., Bočkor, L., Korać, P., Jülg, B. D., Klasić, M., & Zoldoš, V. (2016). Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Research, 44(12), 5615–5628. https://doi.org/10.1093/nar/gkw159

How many times has this paper been cited?

857 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nucleic Acids Research: sign in and open the PDF from this page.

Who wrote this paper?

Aleksandar Vojta, Paula Dobrinić, Vanja Tadić, Luka Bočkor, Petra Korać, Boris Dominik Jülg, Marija Klasić, Vlatka Zoldoš.

What is the DOI of this paper?

10.1093/nar/gkw159, permanently at https://doi.org/10.1093/nar/gkw159. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.